APO Research, Inc.

APO RESEARCH · REPORT

Antibiotics

Selected research

Industry Growth & Trends

Global Antibiotics Industry Growth and Trends Forecast to 2032

Market perspective

The global Antibiotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antibiotics include Astellas Pharma, Bristol Myers Squibb Company, Janssen Pharmaceuticals, Bayer, GlaxoSmithKline, Pfizer, Eli Lilly and Company, Novartis and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antibiotics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antibiotics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antibiotics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antibiotics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antibiotics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antibiotics Market by Company

Astellas Pharma

Bristol Myers Squibb Company

Janssen Pharmaceuticals

Bayer

GlaxoSmithKline

Pfizer

Eli Lilly and Company

Novartis

Sanofi

Abbott

Antibiotics Segment by Type

Cephalosporins

Macrolides

Sulfonamides

Others

Penicillins

Aminoglycosides

Tetracyclines

Antibiotics Segment by Application

Poultry

Livestock

Other

Antibiotics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antibiotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Cephalosporins Table 2. Major Company of Macrolides Table 3. Major Company of Sulfonamides Table 4. Major Company of Others Table 5. Major Company of Penicillins Table 6. Major Company of Aminoglycosides Table 7. Major Company of Tetracyclines Table 8. Global Antibiotics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Antibiotics Sales by Type (2021-2026) & (K Units) Table 10. Global Antibiotics Sales Market Share in Volume by Type (2021-2026) Table 11. Global Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 12. Global Antibiotics Sales Market Share in Value by Type (2021-2026) Table 13. Global Antibiotics Price by Type (2021-2026) & (US$/Unit) Table 14. Global Antibiotics Sales by Type (2027-2032) & (K Units) Table 15. Global Antibiotics Sales Market Share in Volume by Type (2027-2032) Table 16. Global Antibiotics Sales by Type (2027-2032) & (US$ Million) Table 17. Global Antibiotics Sales Market Share in Value by Type (2027-2032) Table 18. Global Antibiotics Price by Type (2027-2032) & (US$/Unit) Table 19. North America Antibiotics Sales by Type (2021-2026) & (K Units) Table 20. North America Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Antibiotics Sales by Type (2021-2026) & (K Units) Table 22. Europe Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Antibiotics Sales by Type (2021-2026) & (K Units) Table 24. Asia-Pacific Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Antibiotics Sales by Type (2021-2026) & (K Units) Table 26. Latin America Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Antibiotics Sales by Type (2021-2026) & (K Units) Table 28. Middle East and Africa Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 29. Antibiotics Industry Trends Table 30. Antibiotics Industry Drivers Table 31. Antibiotics Industry Opportunities and Challenges Table 32. Antibiotics Industry Restraints Table 33. Global Antibiotics Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Antibiotics Revenue Market Share by Company (2021-2026) Table 35. Global Antibiotics Sales by Company (2021-2026) & (K Units) Table 36. Global Antibiotics Sales Share by Company (2021-2026) Table 37. Global Antibiotics Market Price by Company (2021-2026) & (US$/Unit) Table 38. Global Antibiotics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Antibiotics Major Company Production Sites and Headquarters Table 40. Global Antibiotics Company, Product Type & Application Table 41. Global Antibiotics Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Antibiotics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Antibiotics Sales by Region (2021-2026) & (K Units) Table 46. Global Antibiotics Sales Market Share in Volume by Region (2021-2026) Table 47. Global Antibiotics Sales by Region (2021-2026) & (US$ Million) Table 48. Global Antibiotics Sales Market Share in Value by Region (2021-2026) Table 49. Global Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Global Antibiotics Sales by Region (2027-2032) & (K Units) Table 51. Global Antibiotics Sales Market Share in Volume by Region (2027-2032) Table 52. Global Antibiotics Sales by Region (2027-2032) & (US$ Million) Table 53. Global Antibiotics Sales Market Share in Value by Region (2027-2032) Table 54. Global Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 55. Global Antibiotics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Antibiotics Sales by Application (2021-2026) & (K Units) Table 57. Global Antibiotics Sales Market Share in Volume by Application (2021-2026) Table 58. Global Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 59. Global Antibiotics Sales Market Share in Value by Application (2021-2026) Table 60. Global Antibiotics Price by Application (2021-2026) & (US$/Unit) Table 61. Global Antibiotics Sales by Application (2027-2032) & (K Units) Table 62. Global Antibiotics Sales Market Share in Volume by Application (2027-2032) Table 63. Global Antibiotics Sales by Application (2027-2032) & (US$ Million) Table 64. Global Antibiotics Sales Market Share in Value by Application (2027-2032) Table 65. Global Antibiotics Price by Application (2027-2032) & (US$/Unit) Table 66. North America Antibiotics Sales by Application (2021-2026) & (K Units) Table 67. North America Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Antibiotics Sales by Application (2021-2026) & (K Units) Table 69. Europe Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Antibiotics Sales by Application (2021-2026) & (K Units) Table 71. Asia-Pacific Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Antibiotics Sales by Application (2021-2026) & (K Units) Table 73. Latin America Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Antibiotics Sales by Application (2021-2026) & (K Units) Table 75. Middle East and Africa Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 76. Astellas Pharma Company Information Table 77. Astellas Pharma Business Overview Table 78. Astellas Pharma Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Astellas Pharma Antibiotics Product Portfolio Table 80. Astellas Pharma Recent Development Table 81. Bristol Myers Squibb Company Company Information Table 82. Bristol Myers Squibb Company Business Overview Table 83. Bristol Myers Squibb Company Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Bristol Myers Squibb Company Antibiotics Product Portfolio Table 85. Bristol Myers Squibb Company Recent Development Table 86. Janssen Pharmaceuticals Company Information Table 87. Janssen Pharmaceuticals Business Overview Table 88. Janssen Pharmaceuticals Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Janssen Pharmaceuticals Antibiotics Product Portfolio Table 90. Janssen Pharmaceuticals Recent Development Table 91. Bayer Company Information Table 92. Bayer Business Overview Table 93. Bayer Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Bayer Antibiotics Product Portfolio Table 95. Bayer Recent Development Table 96. GlaxoSmithKline Company Information Table 97. GlaxoSmithKline Business Overview Table 98. GlaxoSmithKline Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. GlaxoSmithKline Antibiotics Product Portfolio Table 100. GlaxoSmithKline Recent Development Table 101. Pfizer Company Information Table 102. Pfizer Business Overview Table 103. Pfizer Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Pfizer Antibiotics Product Portfolio Table 105. Pfizer Recent Development Table 106. Eli Lilly and Company Company Information Table 107. Eli Lilly and Company Business Overview Table 108. Eli Lilly and Company Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Eli Lilly and Company Antibiotics Product Portfolio Table 110. Eli Lilly and Company Recent Development Table 111. Novartis Company Information Table 112. Novartis Business Overview Table 113. Novartis Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Novartis Antibiotics Product Portfolio Table 115. Novartis Recent Development Table 116. Sanofi Company Information Table 117. Sanofi Business Overview Table 118. Sanofi Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Sanofi Antibiotics Product Portfolio Table 120. Sanofi Recent Development Table 121. Abbott Company Information Table 122. Abbott Business Overview Table 123. Abbott Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Abbott Antibiotics Product Portfolio Table 125. Abbott Recent Development Table 126. North America Antibiotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. North America Antibiotics Sales by Country (2021-2026) & (K Units) Table 128. North America Antibiotics Sales Market Share by Country (2021-2026) Table 129. North America Antibiotics Sales Forecast by Country (2027-2032) & (K Units) Table 130. North America Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 131. North America Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Antibiotics Market Share by Country (2021-2026) Table 134. North America Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Antibiotics Market Share Forecast by Country (2027-2032) Table 136. Europe Antibiotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Europe Antibiotics Sales by Country (2021-2026) & (K Units) Table 138. Europe Antibiotics Sales Market Share by Country (2021-2026) Table 139. Europe Antibiotics Sales Forecast by Country (2027-2032) & (K Units) Table 140. Europe Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Antibiotics Market Share by Country (2021-2026) Table 144. Europe Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Antibiotics Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Antibiotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Antibiotics Sales by Country (2021-2026) & (K Units) Table 148. Asia-Pacific Antibiotics Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Antibiotics Sales Forecast by Country (2027-2032) & (K Units) Table 150. Asia-Pacific Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Antibiotics Market Share by Country (2021-2026) Table 154. Asia-Pacific Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Antibiotics Market Share Forecast by Country (2027-2032) Table 156. Latin America Antibiotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Latin America Antibiotics Sales by Country (2021-2026) & (K Units) Table 158. Latin America Antibiotics Sales Market Share by Country (2021-2026) Table 159. Latin America Antibiotics Sales Forecast by Country (2027-2032) & (K Units) Table 160. Latin America Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Antibiotics Market Share by Country (2021-2026) Table 164. Latin America Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Antibiotics Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Antibiotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Antibiotics Sales by Country (2021-2026) & (K Units) Table 168. Middle East and Africa Antibiotics Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Antibiotics Sales Forecast by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Antibiotics Market Share by Country (2021-2026) Table 174. Middle East and Africa Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Antibiotics Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Antibiotics Distributors List Table 179. Antibiotics Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Antibiotics Image Figure 2. Global Antibiotics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antibiotics Market Size (2021-2032) & (US$ Million) Figure 4. Global Antibiotics Sales (2021-2032) & (K Units) Figure 5. Cephalosporins Image Figure 6. Global Cephalosporins Sales YoY Growth (2021-2032) & (K Units) Figure 7. Macrolides Image Figure 8. Global Macrolides Sales YoY Growth (2021-2032) & (K Units) Figure 9. Sulfonamides Image Figure 10. Global Sulfonamides Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Penicillins Image Figure 14. Global Penicillins Sales YoY Growth (2021-2032) & (K Units) Figure 15. Aminoglycosides Image Figure 16. Global Aminoglycosides Sales YoY Growth (2021-2032) & (K Units) Figure 17. Tetracyclines Image Figure 18. Global Tetracyclines Sales YoY Growth (2021-2032) & (K Units) Figure 19. Global Antibiotics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Antibiotics Market Share by Type 2025 VS 2032 Figure 21. North America Antibiotics Sales Market Share in Volume by Type in 2025 Figure 22. North America Antibiotics Sales Market Share in Value by Type in 2025 Figure 23. Europe Antibiotics Sales Market Share in Volume by Type in 2025 Figure 24. Europe Antibiotics Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Antibiotics Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Antibiotics Sales Market Share in Value by Type in 2025 Figure 27. Latin America Antibiotics Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Antibiotics Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Antibiotics Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Antibiotics Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Antibiotics Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Poultry Image Figure 34. Global Poultry Sales YoY Growth (2021-2032) & (K Units) Figure 35. Livestock Image Figure 36. Global Livestock Sales YoY Growth (2021-2032) & (K Units) Figure 37. Other Image Figure 38. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Antibiotics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Antibiotics Market Share by Application 2025 VS 2032 Figure 41. North America Antibiotics Sales Market Share in Volume by Application in 2025 Figure 42. North America Antibiotics Sales Market Share in Value by Application in 2025 Figure 43. Europe Antibiotics Sales Market Share in Volume by Application in 2025 Figure 44. Europe Antibiotics Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Antibiotics Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Antibiotics Sales Market Share in Value by Application in 2025 Figure 47. Latin America Antibiotics Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Antibiotics Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Antibiotics Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Antibiotics Sales Market Share in Value by Application in 2025 Figure 51. North America Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Antibiotics Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Antibiotics Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Cephalosporins
  • Macrolides
  • Sulfonamides
  • Others
  • Penicillins
  • Aminoglycosides
  • Tetracyclines
Applications
  • Poultry
  • Livestock
  • Other
Companies covered
  • Astellas Pharma
  • Bristol Myers Squibb Company
  • Janssen Pharmaceuticals
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly and Company
  • Novartis
  • Sanofi
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antibiotics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antibiotics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antibiotics Market by Type
  6. 1.3.1 Cephalosporins
  7. 1.3.2 Macrolides
  8. 1.3.3 Sulfonamides
  9. 1.3.4 Others
  10. 1.3.5 Penicillins
  11. 1.3.6 Aminoglycosides
  12. 1.3.7 Tetracyclines
  13. 1.4 Global Antibiotics Market Size by Type
  14. 1.4.1 Global Antibiotics Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Antibiotics Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Antibiotics Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Antibiotics Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Antibiotics Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Antibiotics Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Antibiotics Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Antibiotics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antibiotics Industry Trends
  2. 2.2 Antibiotics Industry Drivers
  3. 2.3 Antibiotics Industry Opportunities and Challenges
  4. 2.4 Antibiotics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antibiotics Revenue (2021-2026)
  2. 3.2 Global Top Players by Antibiotics Sales (2021-2026)
  3. 3.3 Global Top Players by Antibiotics Price (2021-2026)
  4. 3.4 Global Antibiotics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antibiotics Major Company Production Sites & Headquarters
  6. 3.6 Global Antibiotics Company, Product Type & Application
  7. 3.7 Global Antibiotics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antibiotics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antibiotics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antibiotics Tier 1, Tier 2, and Tier 3
4 Antibiotics Regional Status and Outlook
  1. 4.1 Global Antibiotics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antibiotics Historic Market Size by Region
  3. 4.2.1 Global Antibiotics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antibiotics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antibiotics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antibiotics Forecasted Market Size by Region
  7. 4.3.1 Global Antibiotics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antibiotics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antibiotics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antibiotics by Application
  1. 5.1 Antibiotics Market by Application
  2. 5.1.1 Poultry
  3. 5.1.2 Livestock
  4. 5.1.3 Other
  5. 5.2 Global Antibiotics Market Size by Application
  6. 5.2.1 Global Antibiotics Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Antibiotics Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Antibiotics Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Antibiotics Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Antibiotics Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Antibiotics Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Antibiotics Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Antibiotics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Astellas Pharma
  2. 6.1.1 Astellas Pharma Company Information
  3. 6.1.2 Astellas Pharma Business Overview
  4. 6.1.3 Astellas Pharma Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Astellas Pharma Antibiotics Product Portfolio
  6. 6.1.5 Astellas Pharma Recent Developments
  7. 6.2 Bristol Myers Squibb Company
  8. 6.2.1 Bristol Myers Squibb Company Company Information
  9. 6.2.2 Bristol Myers Squibb Company Business Overview
  10. 6.2.3 Bristol Myers Squibb Company Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bristol Myers Squibb Company Antibiotics Product Portfolio
  12. 6.2.5 Bristol Myers Squibb Company Recent Developments
  13. 6.3 Janssen Pharmaceuticals
  14. 6.3.1 Janssen Pharmaceuticals Company Information
  15. 6.3.2 Janssen Pharmaceuticals Business Overview
  16. 6.3.3 Janssen Pharmaceuticals Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Janssen Pharmaceuticals Antibiotics Product Portfolio
  18. 6.3.5 Janssen Pharmaceuticals Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer Antibiotics Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Antibiotics Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Antibiotics Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Eli Lilly and Company
  38. 6.7.1 Eli Lilly and Company Company Information
  39. 6.7.2 Eli Lilly and Company Business Overview
  40. 6.7.3 Eli Lilly and Company Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Eli Lilly and Company Antibiotics Product Portfolio
  42. 6.7.5 Eli Lilly and Company Recent Developments
  43. 6.8 Novartis
  44. 6.8.1 Novartis Company Information
  45. 6.8.2 Novartis Business Overview
  46. 6.8.3 Novartis Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Novartis Antibiotics Product Portfolio
  48. 6.8.5 Novartis Recent Developments
  49. 6.9 Sanofi
  50. 6.9.1 Sanofi Company Information
  51. 6.9.2 Sanofi Business Overview
  52. 6.9.3 Sanofi Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sanofi Antibiotics Product Portfolio
  54. 6.9.5 Sanofi Recent Developments
  55. 6.10 Abbott
  56. 6.10.1 Abbott Company Information
  57. 6.10.2 Abbott Business Overview
  58. 6.10.3 Abbott Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Abbott Antibiotics Product Portfolio
  60. 6.10.5 Abbott Recent Developments
7 North America by Country
  1. 7.1 North America Antibiotics Sales by Country
  2. 7.1.1 North America Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antibiotics Sales by Country (2021-2026)
  4. 7.1.3 North America Antibiotics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antibiotics Market Size by Country
  6. 7.2.1 North America Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antibiotics Market Size by Country (2021-2026)
  8. 7.2.3 North America Antibiotics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antibiotics Sales by Country
  2. 8.1.1 Europe Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antibiotics Sales by Country (2021-2026)
  4. 8.1.3 Europe Antibiotics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antibiotics Market Size by Country
  6. 8.2.1 Europe Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antibiotics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antibiotics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antibiotics Sales by Country
  2. 9.1.1 Asia-Pacific Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antibiotics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antibiotics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antibiotics Market Size by Country
  6. 9.2.1 Asia-Pacific Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antibiotics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antibiotics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antibiotics Sales by Country
  2. 10.1.1 South America Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antibiotics Sales by Country (2021-2026)
  4. 10.1.3 South America Antibiotics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antibiotics Market Size by Country
  6. 10.2.1 South America Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antibiotics Market Size by Country (2021-2026)
  8. 10.2.3 South America Antibiotics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antibiotics Sales by Country
  2. 11.1.1 Middle East and Africa Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antibiotics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antibiotics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antibiotics Market Size by Country
  6. 11.2.1 Middle East and Africa Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antibiotics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antibiotics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antibiotics Value Chain Analysis
  2. 12.1.1 Antibiotics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antibiotics Production Mode & Process
  7. 12.2 Antibiotics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antibiotics Distributors
  10. 12.2.3 Antibiotics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.